Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Mar 15;91(6):2110–2114. doi: 10.1073/pnas.91.6.2110

Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis.

A Villa 1, L D Notarangelo 1, J P Di Santo 1, P P Macchi 1, D Strina 1, A Frattini 1, F Lucchini 1, C M Patrosso 1, S Giliani 1, E Mantuano 1, et al.
PMCID: PMC43319  PMID: 7907793

Abstract

Recently, CD40L has been identified as the gene responsible for X chromosome-linked hyper-IgM syndrome (HIGM1). CD40L on activated T cells from HIGM1 patients fails to bind B-cell CD40 molecules, and subsequent analysis of CD40L transcripts by reverse transcription PCR demonstrated coding region mutations in these patients. This approach, however, is of limited use for prenatal diagnosis of HIGM1 in the early-gestation fetus. In this report, we have defined the genomic structure of the CD40L gene, which is composed of five exons and four intervening introns. With this information, we have defined at the genomic level the CD40L gene abnormalities for three previously described HIGM1 patients who demonstrated clustered deletions in the CD40L coding region. These different deletions arose from three distinct mechanisms, including (i) a splice donor mutation with exon skipping, (ii) a splice acceptor mutation with utilization of a cryptic splice site, and (iii) a deletion/insertion event with the creation of a new splice acceptor site. In addition, we have performed prenatal evaluation of an 11-week-old fetus at risk for HIGM1. CD40L genomic clones provide a starting point for further studies of the genetic elements that control CD40L expression. Our knowledge of the CD40L gene structure will prove useful for the identification of additional mutations in HIGM1 and for performing genetic counseling about this disease.

Full text

PDF
2110

Images in this article

2111Image
on p.2111
2112Image
on p.2112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen R. C., Armitage R. J., Conley M. E., Rosenblatt H., Jenkins N. A., Copeland N. G., Bedell M. A., Edelhoff S., Disteche C. M., Simoneaux D. K. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993 Feb 12;259(5097):990–993. doi: 10.1126/science.7679801. [DOI] [PubMed] [Google Scholar]
  2. Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Davis-Smith T., Maliszewski C. R. Molecular and biological characterization of a murine ligand for CD40. Nature. 1992 May 7;357(6373):80–82. doi: 10.1038/357080a0. [DOI] [PubMed] [Google Scholar]
  3. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L. S., Stenkamp R., Neubauer M. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993 Jan 29;72(2):291–300. doi: 10.1016/0092-8674(93)90668-g. [DOI] [PubMed] [Google Scholar]
  4. Berg M. A., Argente J., Chernausek S., Gracia R., Guevara-Aguirre J., Hopp M., Pérez-Jurado L., Rosenbloom A., Toledo S. P., Francke U. Diverse growth hormone receptor gene mutations in Laron syndrome. Am J Hum Genet. 1993 May;52(5):998–1005. [PMC free article] [PubMed] [Google Scholar]
  5. Breathnach R., Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem. 1981;50:349–383. doi: 10.1146/annurev.bi.50.070181.002025. [DOI] [PubMed] [Google Scholar]
  6. Brown J. M., Thein S. L., Weatherall D. J., Mar K. M. The spectrum of beta thalassaemia in Burma. Br J Haematol. 1992 Aug;81(4):574–578. doi: 10.1111/j.1365-2141.1992.tb02994.x. [DOI] [PubMed] [Google Scholar]
  7. Canning S., Dryja T. P. Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5044–5048. doi: 10.1073/pnas.86.13.5044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen S. H., Scott C. R. Recombination between two 14-bp homologous sequences as the mechanism for gene deletion in factor IX Seattle 1. Am J Hum Genet. 1990 Dec;47(6):1020–1022. [PMC free article] [PubMed] [Google Scholar]
  9. Cole W. G., Chiodo A. A., Lamande S. R., Janeczko R., Ramirez F., Dahl H. H., Chan D., Bateman J. F. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV. J Biol Chem. 1990 Oct 5;265(28):17070–17077. [PubMed] [Google Scholar]
  10. Dalprà L., Nocera G., Tibiletti M. G., Gramellini F., Agosti S., Oldrini A. Technical aspects and diagnostic problems of direct chromosome analysis using chorionic villus sampling in the first trimester. Hum Reprod. 1986 Feb;1(2):103–106. doi: 10.1093/oxfordjournals.humrep.a136351. [DOI] [PubMed] [Google Scholar]
  11. Dean M., White M. B., Gerrard B., Milunsky A., Amos J. A 22-bp deletion in the coding region of the cystic fibrosis gene. Genomics. 1992 May;13(1):235–236. doi: 10.1016/0888-7543(92)90233-i. [DOI] [PubMed] [Google Scholar]
  12. Deidda G., Novelletto A., Hafez M., el-Ziny M., Terrenato L., Felicetti L. A new beta-thalassaemia frameshift mutation detected by PCR after selective hybridization to immobilized oligonucleotides. Br J Haematol. 1991 Sep;79(1):90–92. doi: 10.1111/j.1365-2141.1991.tb08012.x. [DOI] [PubMed] [Google Scholar]
  13. DiSanto J. P., Bonnefoy J. Y., Gauchat J. F., Fischer A., de Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature. 1993 Feb 11;361(6412):541–543. doi: 10.1038/361541a0. [DOI] [PubMed] [Google Scholar]
  14. Fuleihan R., Ramesh N., Loh R., Jabara H., Rosen R. S., Chatila T., Fu S. M., Stamenkovic I., Geha R. S. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2170–2173. doi: 10.1073/pnas.90.6.2170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gauchat J. F., Aubry J. P., Mazzei G., Life P., Jomotte T., Elson G., Bonnefoy J. Y. Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett. 1993 Jan 11;315(3):259–266. doi: 10.1016/0014-5793(93)81175-y. [DOI] [PubMed] [Google Scholar]
  16. Giacalone J. P., Francke U. Common sequence motifs at the rearrangement sites of a constitutional X/autosome translocation and associated deletion. Am J Hum Genet. 1992 Apr;50(4):725–741. [PMC free article] [PubMed] [Google Scholar]
  17. Graf D., Korthäuer U., Mages H. W., Senger G., Kroczek R. A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol. 1992 Dec;22(12):3191–3194. doi: 10.1002/eji.1830221226. [DOI] [PubMed] [Google Scholar]
  18. Granell R., Solera J., Carrasco S., Molano J. Identification of a nonframeshift 84-bp deletion in exon 13 of the cystic fibrosis gene. Am J Hum Genet. 1992 May;50(5):1022–1026. [PMC free article] [PubMed] [Google Scholar]
  19. Groden J., Gelbert L., Thliveris A., Nelson L., Robertson M., Joslyn G., Samowitz W., Spirio L., Carlson M., Burt R. Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. Am J Hum Genet. 1993 Feb;52(2):263–272. [PMC free article] [PubMed] [Google Scholar]
  20. Hogge W. A., Schonberg S. A., Golbus M. S. Prenatal diagnosis by chorionic villus sampling: lessons of the first 600 cases. Prenat Diagn. 1985 Nov-Dec;5(6):393–400. doi: 10.1002/pd.1970050605. [DOI] [PubMed] [Google Scholar]
  21. Hollenbaugh D., Grosmaire L. S., Kullas C. D., Chalupny N. J., Braesch-Andersen S., Noelle R. J., Stamenkovic I., Ledbetter J. A., Aruffo A. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992 Dec;11(12):4313–4321. doi: 10.1002/j.1460-2075.1992.tb05530.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Huang S. Z., Xu Y. H., Zeng F. Y., Wu D. F., Ren Z. R., Zeng Y. T. A novel beta-thalassaemia mutation: deletion of 4 bp (-AAAC) in the 5' transcriptional sequence. Br J Haematol. 1991 May;78(1):125–126. doi: 10.1111/j.1365-2141.1991.tb04396.x. [DOI] [PubMed] [Google Scholar]
  23. Jaruzelska J., Melle D., Matuszak R., Borski K., Munnich A. A new 15 bp deletion in exon 11 of the phenylalanine hydroxylase gene in phenylketonuria. Hum Mol Genet. 1992 Dec;1(9):763–764. doi: 10.1093/hmg/1.9.763. [DOI] [PubMed] [Google Scholar]
  24. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  25. Kontusaari S., Tromp G., Kuivaniemi H., Ladda R. L., Prockop D. J. Inheritance of an RNA splicing mutation (G+ 1 IVS20) in the type III procollagen gene (COL3A1) in a family having aortic aneurysms and easy bruisability: phenotypic overlap between familial arterial aneurysms and Ehlers-Danlos syndrome type IV. Am J Hum Genet. 1990 Jul;47(1):112–120. [PMC free article] [PubMed] [Google Scholar]
  26. Korthäuer U., Graf D., Mages H. W., Brière F., Padayachee M., Malcolm S., Ugazio A. G., Notarangelo L. D., Levinsky R. J., Kroczek R. A. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993 Feb 11;361(6412):539–541. doi: 10.1038/361539a0. [DOI] [PubMed] [Google Scholar]
  27. Lee B., D'Alessio M., Vissing H., Ramirez F., Steinmann B., Superti-Furga A. Characterization of a large deletion associated with a polymorphic block of repeated dinucleotides in the type III procollagen gene (COL3A1) of a patient with Ehlers-Danlos syndrome type IV. Am J Hum Genet. 1991 Mar;48(3):511–517. [PMC free article] [PubMed] [Google Scholar]
  28. Lehrman M. A., Russell D. W., Goldstein J. L., Brown M. S. Exon-Alu recombination deletes 5 kilobases from the low density lipoprotein receptor gene, producing a null phenotype in familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3679–3683. doi: 10.1073/pnas.83.11.3679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Leoni G. B., Rosatelli M. C., Cossu G., Pischedda M. C., De Virgiliis S., Cao A. A novel cystic fibrosis mutation: deletion of seventeen nucleotides at the exon 10-intron 10 boundary of the CFTR gene, in a Sardinian patient. Hum Mol Genet. 1993 Jan;2(1):83–84. doi: 10.1093/hmg/2.1.83. [DOI] [PubMed] [Google Scholar]
  30. Li L., Bray P. F. Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia. Am J Hum Genet. 1993 Jul;53(1):140–149. [PMC free article] [PubMed] [Google Scholar]
  31. Macke J. P., Davenport C. M., Jacobson S. G., Hennessey J. C., Gonzalez-Fernandez F., Conway B. P., Heckenlively J., Palmer R., Maumenee I. H., Sieving P. Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin. Am J Hum Genet. 1993 Jul;53(1):80–89. [PMC free article] [PubMed] [Google Scholar]
  32. Matsuo M., Masumura T., Nishio H., Nakajima T., Kitoh Y., Takumi T., Koga J., Nakamura H. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. J Clin Invest. 1991 Jun;87(6):2127–2131. doi: 10.1172/JCI115244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Milewicz D. M., Witz A. M., Smith A. C., Manchester D. K., Waldstein G., Byers P. H. Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring. Am J Hum Genet. 1993 Jul;53(1):62–70. [PMC free article] [PubMed] [Google Scholar]
  34. Nakajima H., Kono N., Yamasaki T., Hotta K., Kawachi M., Kuwajima M., Noguchi T., Tanaka T., Tarui S. Genetic defect in muscle phosphofructokinase deficiency. Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5'-splice site. J Biol Chem. 1990 Jun 5;265(16):9392–9395. [PubMed] [Google Scholar]
  35. Nizetić D., Zehetner G., Monaco A. P., Gellen L., Young B. D., Lehrach H. Construction, arraying, and high-density screening of large insert libraries of human chromosomes X and 21: their potential use as reference libraries. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3233–3237. doi: 10.1073/pnas.88.8.3233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Notarangelo L. D., Duse M., Ugazio A. G. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3(2):101–121. [PubMed] [Google Scholar]
  37. Olschwang S., Laurent-Puig P., Groden J., White R., Thomas G. Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene. Am J Hum Genet. 1993 Feb;52(2):273–279. [PMC free article] [PubMed] [Google Scholar]
  38. Oner R., Oner C., Wilson J. B., Tamagnini G. P., Ribeiro L. M., Huisman T. H. Dominant beta-thalassaemia trait in a Portuguese family is caused by a deletion of (G)TGGCTGGTGT(G) and an insertion of (G)GCAG(G) in codons 134, 135, 136 and 137 of the beta-globin gene. Br J Haematol. 1991 Oct;79(2):306–310. doi: 10.1111/j.1365-2141.1991.tb04538.x. [DOI] [PubMed] [Google Scholar]
  39. Orkin S. H., Kazazian H. H., Jr The mutation and polymorphism of the human beta-globin gene and its surrounding DNA. Annu Rev Genet. 1984;18:131–171. doi: 10.1146/annurev.ge.18.120184.001023. [DOI] [PubMed] [Google Scholar]
  40. Padayachee M., Levinsky R. J., Kinnon C., Finn A., McKeown C., Feighery C., Notarangelo L. D., Hendriks R. W., Read A. P., Malcolm S. Mapping of the X linked form of hyper IgM syndrome (HIGM1) J Med Genet. 1993 Mar;30(3):202–205. doi: 10.1136/jmg.30.3.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pan Y., Metzenberg A., Das S., Jing B., Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet. 1992 Oct;2(2):103–106. doi: 10.1038/ng1092-103. [DOI] [PubMed] [Google Scholar]
  42. Poort S. R., Briët E., Bertina R. M., Reitsma P. H. Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B. Thromb Haemost. 1990 Nov 30;64(3):379–384. [PubMed] [Google Scholar]
  43. Sakuraba H., Eng C. M., Desnick R. J., Bishop D. F. Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease. Genomics. 1992 Apr;12(4):643–650. doi: 10.1016/0888-7543(92)90288-4. [DOI] [PubMed] [Google Scholar]
  44. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schapiro B. L., Newburger P. E., Klempner M. S., Dinauer M. C. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med. 1991 Dec 19;325(25):1786–1790. doi: 10.1056/NEJM199112193252506. [DOI] [PubMed] [Google Scholar]
  46. Spriggs M. K., Armitage R. J., Strockbine L., Clifford K. N., Macduff B. M., Sato T. A., Maliszewski C. R., Fanslow W. C. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med. 1992 Dec 1;176(6):1543–1550. doi: 10.1084/jem.176.6.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Stamenkovic I., Clark E. A., Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 1989 May;8(5):1403–1410. doi: 10.1002/j.1460-2075.1989.tb03521.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tassabehji M., Read A. P., Newton V. E., Patton M., Gruss P., Harris R., Strachan T. Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat Genet. 1993 Jan;3(1):26–30. doi: 10.1038/ng0193-26. [DOI] [PubMed] [Google Scholar]
  49. Treisman R., Proudfoot N. J., Shander M., Maniatis T. A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing. Cell. 1982 Jul;29(3):903–911. doi: 10.1016/0092-8674(82)90452-4. [DOI] [PubMed] [Google Scholar]
  50. Tuddenham E. G., Cooper D. N., Gitschier J., Higuchi M., Hoyer L. W., Yoshioka A., Peake I. R., Schwaab R., Olek K., Kazazian H. H. Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucleic Acids Res. 1991 Sep 25;19(18):4821–4833. doi: 10.1093/nar/19.18.4821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zielenski J., Bozon D., Kerem B., Markiewicz D., Durie P., Rommens J. M., Tsui L. C. Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991 May;10(1):229–235. doi: 10.1016/0888-7543(91)90504-8. [DOI] [PubMed] [Google Scholar]
  52. de Chasseval R., de Villartay J. P. Functional characterization of the promoter for the human germ-line T cell receptor J alpha (TEA) transcript. Eur J Immunol. 1993 Jun;23(6):1294–1298. doi: 10.1002/eji.1830230616. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES